Next Article in Journal
Self-Rated Oral Health as a Valid Measure of Oral Health Status in Adults Living in Rural Australia
Next Article in Special Issue
Patterns of Third-Molar-Pericoronitis-Related Pain: A Morphometrical Observational Retrospective Study
Previous Article in Journal
Type 2 Diabetes Patients’ Views of Local Pharmacists and Fulfilment with Pharmaceutical Diabetes Care in Syria’s Latakia Governorate: An Online Survey Research
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Unveiling Neurovascular Orofacial Pain: An Underdiagnosed Form of Chronic Orofacial Pain

Faculty of Dental Medicine, Department of Oral Medicine, Sedation and Imaging, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem 91120, Israel
Healthcare 2023, 11(12), 1722; https://doi.org/10.3390/healthcare11121722
Submission received: 6 June 2023 / Accepted: 11 June 2023 / Published: 12 June 2023
(This article belongs to the Special Issue Healthcare and Orofacial Pain Management)
Neurovascular orofacial pain (NVOP) is a relatively rare type of facial pain syndrome that shares similarities with migraine, orofacial migraine, and trigeminal autonomic cephalalgias (TACs). NVOP is characterized by pain in the orofacial region. Diagnosing NVOP can be particularly challenging. Recently, it was included as a recognized diagnosis in the latest classification of orofacial pain—ICOP [1].
In this editorial, we explore the symptoms, causes, diagnosis, and treatment of NVOP [2,3,4].
  • Symptoms:
NVOP typically presents as episodic, unilateral or bilateral pain or discomfort in the orofacial region. The pain is often described as a dull ache, pressure, or throbbing and may migrate between teeth. Additional symptoms can include sensitivity to light, sound, or odors; nausea; vomiting; visual disturbances; and numbness or tingling of the face, mouth, or tongue [5,6].
  • Causes:
The exact cause of NVOP is unknown, but it is thought to be related to neurovascular mechanisms that contribute to other types of migraines. These mechanisms involve changes in the blood vessels and nerves in the brain, resulting in inflammation, blood vessel dilation, and activation of pain pathways. NVOP can be triggered by various factors such as stress, hormonal changes, certain foods, weather or altitude changes, and physical exertion [5].
  • Diagnosis:
Diagnosing NVOP can be challenging due to its resemblance to other dental and facial pain disorders such as acute pulpitis, trigeminal neuralgia [7,8], or temporomandibular joint disorder [9,10]. A thorough medical history and physical examination are crucial for ruling out other potential causes of facial pain, such as dental problems or sinusitis. Imaging studies such as MRI or CT scans may be conducted to exclude other neurological conditions. The diagnosis of NVOP is typically based on characteristic symptoms and may require consultation with a headache specialist or neurologist [6].
  • Treatment:
The NVOP treatment approach usually involves a combination of lifestyle modifications, medications, and nonpharmacological therapies. Lifestyle modifications may include avoiding triggers, maintaining regular sleep patterns, and employing stress-reduction techniques such as meditation or yoga. Naturally, success depends on individuals’ expectations and coping strategies [11]. Medications commonly used to manage migraines can be effective for NVOP. For infrequent attacks (less than five per month), drugs that can be taken on an as-needed basis, such as triptans (migraine-specific medication) and NSAIDs such as ibuprofen, may be suitable. These medications must be taken at the onset of each attack for optimal pain relief. If NVOP becomes chronic, with more than four severe pain attacks per month, a preventive approach is recommended using medications such as beta blockers, antiepileptic drugs, antidepressants, or newer CGRP receptor antagonists specifically developed for migraine relief. Nonpharmacological therapies such as biofeedback, acupuncture, or physical therapy can also be beneficial in alleviating symptoms [12].
In conclusion, neurovascular orofacial pain or NVOP is a relatively rare type of facial pain syndrome that shares similarities with other facial pain disorders, including migraines. NVOP is characterized by episodic pain or discomfort in the orofacial region, which may migrate between the teeth. Treatment typically involves lifestyle modifications, medications, and nonpharmacological therapies. If you experience symptoms of NVOP, medical attention must be sought to exclude other potential causes and receive appropriate treatment.

Conflicts of Interest

The author declares no conflict of interest.

References

  1. International Classification of Orofacial Pain, 1st edition (ICOP). Cephalalgia Int. J. Headache 2020, 40, 129–221. [CrossRef] [Green Version]
  2. Benoliel, R.; Sharav, Y.; Eliav, E. Neurovascular orofacial pain. J. Am. Dent. Assoc. 2010, 141, 1094–1096. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Benoliel, R.; Sharav, Y. Pain remapping in migraine to the orofacial region. Headache 2009, 49, 1353–1354. [Google Scholar] [CrossRef]
  4. Benoliel, R.; Elishoov, H.; Sharav, Y. Orofacial pain with vascular-type features. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1997, 84, 506–512. [Google Scholar] [CrossRef] [PubMed]
  5. Sharav, Y.; Haviv, Y.; Benoliel, R. Orofacial Migraine or Neurovascular Orofacial Pain from Pathogenesis to Treatment. Int. J. Mol. Sci. 2023, 24, 2456. [Google Scholar] [CrossRef] [PubMed]
  6. Haviv, Y.; Zini, A.; Keshet, N.; Almoznino, G.; Benoliel, R.; Sharav, Y. Features of Neurovascular Orofacial Pain Compared to Painful Posttraumatic Trigeminal Neuropathy. J. Oral Facial Pain Headache 2020, 34, 121–128. [Google Scholar] [CrossRef] [PubMed]
  7. Benoliel, R.; Zini, A.; Khan, J.; Almoznino, G.; Sharav, Y.; Haviv, Y. Trigeminal neuralgia (part II): Factors affecting early pharmacotherapeutic outcome. Cephalalgia Int. J. Headache 2016, 36, 747–759. [Google Scholar] [CrossRef] [PubMed]
  8. Haviv, Y.; Khan, J.; Zini, A.; Almoznino, G.; Sharav, Y.; Benoliel, R. Trigeminal neuralgia (part I): Revisiting the clinical phenotype. Cephalalgia Int. J. Headache 2016, 36, 730–746. [Google Scholar] [CrossRef] [PubMed]
  9. Haviv, Y.; Zini, A.; Sharav, Y.; Almoznino, G.; Benoliel, R. Nortriptyline Compared to Amitriptyline for the Treatment of Persistent Masticatory Myofascial Pain. J. Oral Facial Pain Headache 2019, 33, 7–13. [Google Scholar] [CrossRef] [PubMed]
  10. Almoznino, G.; Barsheshet, S.; Mazor, S.; Yanko, R.; Sharav, Y.; Haviv, Y. Long-term adherence to oral stabilization splints: Does pain matter? Quintessence Int. 2021, 53, 68–76. [Google Scholar] [CrossRef] [PubMed]
  11. Haviv, Y.; Mazor, S.; Shani, M.; Yanko, R.; Aframian, D.J.; Zadik, Y.; Ben-David, S.; Wilensky, A.; Sharav, Y. The Impact of Expectation for Pain Relief on Orofacial Pain Treatment Outcomes. Front. Psychiatry 2021, 12, 734986. [Google Scholar] [CrossRef] [PubMed]
  12. Sharav, Y.; Benolel, R. Orofacial Pain and Headache, 2nd ed.; Quintessence: Chicago, IL, USA, 2015. [Google Scholar]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Haviv, Y. Unveiling Neurovascular Orofacial Pain: An Underdiagnosed Form of Chronic Orofacial Pain. Healthcare 2023, 11, 1722. https://doi.org/10.3390/healthcare11121722

AMA Style

Haviv Y. Unveiling Neurovascular Orofacial Pain: An Underdiagnosed Form of Chronic Orofacial Pain. Healthcare. 2023; 11(12):1722. https://doi.org/10.3390/healthcare11121722

Chicago/Turabian Style

Haviv, Yaron. 2023. "Unveiling Neurovascular Orofacial Pain: An Underdiagnosed Form of Chronic Orofacial Pain" Healthcare 11, no. 12: 1722. https://doi.org/10.3390/healthcare11121722

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop